| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphoprotein binding | 1.45e-06 | 117 | 137 | 8 | GO:0051219 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.17e-04 | 37 | 137 | 4 | GO:0140658 | |
| GeneOntologyCellularComponent | cell-cell junction | EPPK1 DSG1 DSG3 SPECC1L LCK PCDH12 TENM2 YWHAH PTK7 KCNA5 TIAM1 DLG1 DLG2 LYN | 2.95e-05 | 591 | 135 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 7.19e-05 | 13 | 135 | 3 | GO:0030877 | |
| GeneOntologyCellularComponent | condensed chromosome | 1.75e-04 | 307 | 135 | 9 | GO:0000793 | |
| GeneOntologyCellularComponent | anchoring junction | EPPK1 DSG1 DSG3 DDR2 SPECC1L LCK PCDH12 TENM2 YWHAG YWHAH PTK7 KCNA5 TIAM1 DLG1 DLG2 DIXDC1 LYN | 1.87e-04 | 976 | 135 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | chromosomal region | SP100 SMARCA5 SMCHD1 SMC6 CHD4 TEX14 XRCC1 CSNK1A1L CSNK1A1 SUV39H1 | 4.15e-04 | 421 | 135 | 10 | GO:0098687 |
| GeneOntologyCellularComponent | apicolateral plasma membrane | 7.67e-04 | 28 | 135 | 3 | GO:0016327 | |
| GeneOntologyCellularComponent | pericentriolar material | 7.67e-04 | 28 | 135 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | cerebellar granule cell to Purkinje cell synapse | 8.51e-04 | 7 | 135 | 2 | GO:0150048 | |
| GeneOntologyCellularComponent | NURF complex | 8.51e-04 | 7 | 135 | 2 | GO:0016589 | |
| GeneOntologyCellularComponent | B-WICH complex | 1.13e-03 | 8 | 135 | 2 | GO:0110016 | |
| Domain | SLIDE | 4.88e-05 | 2 | 131 | 2 | IPR015195 | |
| Domain | ISWI_HAND-dom | 4.88e-05 | 2 | 131 | 2 | IPR015194 | |
| Domain | SLIDE | 4.88e-05 | 2 | 131 | 2 | PF09111 | |
| Domain | HAND | 4.88e-05 | 2 | 131 | 2 | PF09110 | |
| Domain | ISWI | 4.88e-05 | 2 | 131 | 2 | IPR029915 | |
| Domain | SNF2_N | 7.14e-05 | 32 | 131 | 4 | IPR000330 | |
| Domain | SNF2_N | 7.14e-05 | 32 | 131 | 4 | PF00176 | |
| Domain | Rhs_assc_core | 1.46e-04 | 3 | 131 | 2 | IPR022385 | |
| Domain | DBINO | 1.46e-04 | 3 | 131 | 2 | IPR020838 | |
| Domain | DBINO | 1.46e-04 | 3 | 131 | 2 | PF13892 | |
| Domain | CarboxyPept-like_regulatory | 2.13e-04 | 17 | 131 | 3 | IPR008969 | |
| Domain | RUN | 2.55e-04 | 18 | 131 | 3 | SM00593 | |
| Domain | Tox-GHH_dom | 2.90e-04 | 4 | 131 | 2 | IPR028916 | |
| Domain | MAGUK_N_PEST | 2.90e-04 | 4 | 131 | 2 | PF10608 | |
| Domain | PDZ_assoc | 2.90e-04 | 4 | 131 | 2 | PF10600 | |
| Domain | Desmoglein | 2.90e-04 | 4 | 131 | 2 | IPR009123 | |
| Domain | DLG1_PEST_dom | 2.90e-04 | 4 | 131 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 2.90e-04 | 4 | 131 | 2 | IPR019583 | |
| Domain | Tox-GHH | 2.90e-04 | 4 | 131 | 2 | PF15636 | |
| Domain | MAGUK_N_PEST | 2.90e-04 | 4 | 131 | 2 | SM01277 | |
| Domain | DLG1 | 2.90e-04 | 4 | 131 | 2 | IPR016313 | |
| Domain | Ten_N | 2.90e-04 | 4 | 131 | 2 | IPR009471 | |
| Domain | Ten_N | 2.90e-04 | 4 | 131 | 2 | PF06484 | |
| Domain | TENEURIN_N | 2.90e-04 | 4 | 131 | 2 | PS51361 | |
| Domain | Pkinase_Tyr | 2.98e-04 | 129 | 131 | 6 | PF07714 | |
| Domain | RUN | 3.01e-04 | 19 | 131 | 3 | PS50826 | |
| Domain | RUN | 3.01e-04 | 19 | 131 | 3 | PF02759 | |
| Domain | Run_dom | 3.01e-04 | 19 | 131 | 3 | IPR004012 | |
| Domain | Tyr_kinase_cat_dom | 3.87e-04 | 88 | 131 | 5 | IPR020635 | |
| Domain | TyrKc | 3.87e-04 | 88 | 131 | 5 | SM00219 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.28e-04 | 138 | 131 | 6 | IPR001245 | |
| Domain | YD | 4.82e-04 | 5 | 131 | 2 | IPR006530 | |
| Domain | PROTEIN_KINASE_TYR | 6.05e-04 | 97 | 131 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 6.05e-04 | 97 | 131 | 5 | IPR008266 | |
| Domain | SMC_hinge | 7.19e-04 | 6 | 131 | 2 | SM00968 | |
| Domain | SMC_hinge | 7.19e-04 | 6 | 131 | 2 | PF06470 | |
| Domain | SMC_hinge | 7.19e-04 | 6 | 131 | 2 | IPR010935 | |
| Domain | 14_3_3 | 1.00e-03 | 7 | 131 | 2 | SM00101 | |
| Domain | 1433_1 | 1.00e-03 | 7 | 131 | 2 | PS00796 | |
| Domain | 1433_2 | 1.00e-03 | 7 | 131 | 2 | PS00797 | |
| Domain | Desmosomal_cadherin | 1.00e-03 | 7 | 131 | 2 | IPR009122 | |
| Domain | 14-3-3_domain | 1.00e-03 | 7 | 131 | 2 | IPR023410 | |
| Domain | 14-3-3_CS | 1.00e-03 | 7 | 131 | 2 | IPR023409 | |
| Domain | 14-3-3 | 1.00e-03 | 7 | 131 | 2 | PF00244 | |
| Domain | HMG_box_dom | 1.12e-03 | 65 | 131 | 4 | IPR009071 | |
| Domain | 14-3-3 | 1.33e-03 | 8 | 131 | 2 | IPR000308 | |
| Domain | RecF/RecN/SMC_N | 1.33e-03 | 8 | 131 | 2 | IPR003395 | |
| Domain | SMC_N | 1.33e-03 | 8 | 131 | 2 | PF02463 | |
| Domain | Glyco_transf_8 | 2.12e-03 | 10 | 131 | 2 | PF01501 | |
| Domain | Flavoprot_Pyr_Nucl_cyt_Rdtase | 2.12e-03 | 10 | 131 | 2 | IPR001709 | |
| Domain | Glyco_trans_8 | 2.12e-03 | 10 | 131 | 2 | IPR002495 | |
| Domain | - | SMARCA5 SMC6 PEX6 ABCC5 CHD4 RAD54L2 SMC2 ABCB8 SMARCA1 SMG9 DLG1 N4BP2L2 DLG2 | 2.26e-03 | 746 | 131 | 13 | 3.40.50.300 |
| Domain | Prot_kinase_dom | 2.37e-03 | 489 | 131 | 10 | IPR000719 | |
| Domain | DEAH_ATP_HELICASE | 2.38e-03 | 38 | 131 | 3 | PS00690 | |
| Domain | PROTEIN_KINASE_DOM | 2.51e-03 | 493 | 131 | 10 | PS50011 | |
| Domain | RECEPTOR_TYR_KIN_II | 3.08e-03 | 12 | 131 | 2 | PS00239 | |
| Domain | SH3_2 | 3.15e-03 | 86 | 131 | 4 | PF07653 | |
| Domain | SH3_2 | 3.15e-03 | 86 | 131 | 4 | IPR011511 | |
| Domain | NHL | 3.62e-03 | 13 | 131 | 2 | PS51125 | |
| Domain | SH3 | 4.21e-03 | 216 | 131 | 6 | SM00326 | |
| Domain | SH3 | 4.21e-03 | 216 | 131 | 6 | PS50002 | |
| Domain | ER_TARGET | 4.37e-03 | 47 | 131 | 3 | PS00014 | |
| Domain | SH3_domain | 4.60e-03 | 220 | 131 | 6 | IPR001452 | |
| Domain | Kinase-like_dom | 4.90e-03 | 542 | 131 | 10 | IPR011009 | |
| Domain | Guanylate_kinase_CS | 5.49e-03 | 16 | 131 | 2 | IPR020590 | |
| Domain | P4Hc | 5.49e-03 | 16 | 131 | 2 | SM00702 | |
| Domain | Pro_4_hyd_alph | 5.49e-03 | 16 | 131 | 2 | IPR006620 | |
| Domain | SH2 | 5.59e-03 | 101 | 131 | 4 | PF00017 | |
| Domain | SH3_1 | 6.02e-03 | 164 | 131 | 5 | PF00018 | |
| Domain | Glycoside_hydrolase_SF | 6.12e-03 | 53 | 131 | 3 | IPR017853 | |
| Domain | P-loop_NTPase | SMARCA5 SMC6 PEX6 ABCC5 CHD4 RAD54L2 SMC2 ABCB8 SMARCA1 SMG9 DLG1 N4BP2L2 DLG2 | 6.64e-03 | 848 | 131 | 13 | IPR027417 |
| Domain | Helicase_C | 6.84e-03 | 107 | 131 | 4 | PF00271 | |
| Domain | HELICc | 6.84e-03 | 107 | 131 | 4 | SM00490 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 6.64e-05 | 12 | 97 | 3 | MM14835 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 6.64e-05 | 12 | 97 | 3 | M11773 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PRPF31 SP100 SMARCA5 TMA16 EPPK1 RARS1 DSG1 DSG3 SMCHD1 ECD SPECC1L SMC2 YWHAG YWHAH SF3B1 CSNK1A1 NOM1 SMARCA1 DLG1 RBM8A LYN | 2.70e-08 | 1257 | 138 | 21 | 36526897 |
| Pubmed | MYCBP2 APC2 CHD4 GRIK5 SPECC1L SMC2 TMEM132B ZBTB1 TENM2 YWHAG YWHAH CSNK1A1L SF3B1 CSNK1A1 DLG1 DLG2 DIXDC1 TNR | 5.58e-08 | 963 | 138 | 18 | 28671696 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | PRPF31 SMARCA5 EPPK1 SMCHD1 ZDBF2 CHD4 RAD54L2 YWHAG YWHAH SF3B1 C5orf24 INTS13 NOM1 CLNS1A | 9.31e-08 | 583 | 138 | 14 | 29844126 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | PRPF31 SUPT3H TMA16 DSG1 MYCBP2 CHD4 CALML5 YWHAH NMD3 POLR3B P3H1 CLNS1A DLG1 N4BP2L2 UGGT2 RBM8A LRRC14 NIN | 1.05e-07 | 1005 | 138 | 18 | 19615732 |
| Pubmed | Peli1 Modulates the Subcellular Localization and Activity of Mdmx. | 1.15e-07 | 12 | 138 | 4 | 29523541 | |
| Pubmed | PLEKHB2 MYCBP2 RBL2 APC2 ABCC5 CHD4 ACTR3B RAD54L2 YWHAG YWHAH RUFY2 POLR3B SF3B1 TIAM1 RSPH1 GEMIN8 SGSM2 DLG1 N4BP2L2 DLG2 | 1.87e-07 | 1285 | 138 | 20 | 35914814 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PRPF31 SMARCA5 EPPK1 RARS1 DSG1 MYCBP2 SMCHD1 CHD4 SPECC1L XRCC1 SMC2 YWHAG YWHAH SF3B1 BBS7 RBM8A LYN | 7.01e-07 | 1024 | 138 | 17 | 24711643 |
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 12923167 | ||
| Pubmed | SLC25A46 EPPK1 APC2 YWHAG CSNK1A1L OXCT1 CSNK1A1 PRICKLE2 DLG1 DLG2 TNR | 1.28e-06 | 430 | 138 | 11 | 32581705 | |
| Pubmed | DOCK4 ABAT RARS1 DSG1 MYCBP2 POR ZDBF2 ACTR3B TENM2 YWHAG YWHAH PTK7 OXCT1 SF3B1 PRICKLE2 DLG1 DLG2 | 2.95e-06 | 1139 | 138 | 17 | 36417873 | |
| Pubmed | Effects of Fam83h truncation mutation on enamel developmental defects in male C57/BL6J mice. | 5.05e-06 | 9 | 138 | 3 | 36272714 | |
| Pubmed | Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. | 5.05e-06 | 9 | 138 | 3 | 16511560 | |
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 9601641 | ||
| Pubmed | MYCBP2 ECD POR RAB11FIP1 PTK7 NOMO1 NBAS SF3B1 DNAJC28 TIAM1 BBS7 P3H1 GEMIN8 CLNS1A SIK2 DLG1 UGGT2 PLOD2 NIN | 7.01e-06 | 1487 | 138 | 19 | 33957083 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PRPF31 SMARCA5 RARS1 DSG1 MYCBP2 SMCHD1 CASP8 CHD4 SMC2 YWHAG NMD3 POLR3B OXCT1 SF3B1 C5orf24 SMARCA1 RBM8A RIOK2 | 7.24e-06 | 1353 | 138 | 18 | 29467282 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | RARS1 DSG3 GBE1 KCTD21 XRCC1 YWHAG OXCT1 CSNK1A1 NOM1 PRICKLE2 NUB1 RBM8A NIN | 7.58e-06 | 732 | 138 | 13 | 34732716 |
| Pubmed | TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. | 8.88e-06 | 33 | 138 | 4 | 33567268 | |
| Pubmed | DPYSL3 EPPK1 MYCBP2 XRCC1 PTK7 NOMO1 PTPN11 BRD4 SMARCA1 RBM6 UGGT2 | 9.87e-06 | 533 | 138 | 11 | 25544563 | |
| Pubmed | NAT8L DPYSL3 LHX4 SMC6 NOMO1 CSNK1A1L CSNK1A1 BBS7 BRD4 NUB1 DIXDC1 C1QTNF4 RIOK2 MAB21L1 LARGE1 | 1.19e-05 | 1006 | 138 | 15 | 15226823 | |
| Pubmed | SMARCA5 EPPK1 DSG1 SMCHD1 CHD4 CALML5 RAB11FIP1 SMC2 ZBTB1 YWHAG SF3B1 RBM8A | 1.21e-05 | 652 | 138 | 12 | 31180492 | |
| Pubmed | 1.28e-05 | 128 | 138 | 6 | 23858473 | ||
| Pubmed | PRPF31 SMARCA5 SMCHD1 SMC6 GBE1 CHD4 XRCC1 SMC2 PTPN11 POLR3B SF3B1 CSNK1A1 INTS13 BRD4 RBM8A | 1.31e-05 | 1014 | 138 | 15 | 32416067 | |
| Pubmed | Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. | 1.31e-05 | 12 | 138 | 3 | 19172738 | |
| Pubmed | SMARCA5 SMCHD1 SPECC1L XRCC1 ACTR3B SF3B1 CSNK1A1 P3H1 SMARCA1 DLG1 RBM8A LYN | 1.37e-05 | 660 | 138 | 12 | 32780723 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.40e-05 | 358 | 138 | 9 | 32460013 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PLEKHB2 DOCK4 EPPK1 RARS1 DSG1 MYCBP2 XRCC1 ACTR3B CALML5 RAB11FIP1 SMC2 YWHAG SF3B1 TIAM1 NOM1 LYN PLOD2 | 1.41e-05 | 1284 | 138 | 17 | 17353931 |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28620161 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23354688 | ||
| Pubmed | Tissue-specific distribution of mouse casein kinase I alpha mRNA. | 1.56e-05 | 2 | 138 | 2 | 9522121 | |
| Pubmed | Differential effects of desmoglein 1 and desmoglein 3 on desmosome formation. | 1.56e-05 | 2 | 138 | 2 | 12485422 | |
| Pubmed | CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling. | 1.56e-05 | 2 | 138 | 2 | 37723657 | |
| Pubmed | Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice. | 1.56e-05 | 2 | 138 | 2 | 36929849 | |
| Pubmed | Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization. | 1.56e-05 | 2 | 138 | 2 | 34728626 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 35695793 | ||
| Pubmed | A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia. | 1.56e-05 | 2 | 138 | 2 | 17360941 | |
| Pubmed | Exploring the role of casein kinase 1α splice variants across cancer cell lines. | 1.56e-05 | 2 | 138 | 2 | 38852281 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23690993 | ||
| Pubmed | Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion. | 1.56e-05 | 2 | 138 | 2 | 12164920 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23822953 | ||
| Pubmed | Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice. | 1.56e-05 | 2 | 138 | 2 | 36542875 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12970345 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 1720352 | ||
| Pubmed | Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3. | 1.56e-05 | 2 | 138 | 2 | 17640963 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21602032 | ||
| Pubmed | The association of 14-3-3gamma and actin plays a role in cell division and apoptosis in astrocytes. | 1.56e-05 | 2 | 138 | 2 | 12176032 | |
| Pubmed | SNF2H interacts with XRCC1 and is involved in repair of H2O2-induced DNA damage. | 1.56e-05 | 2 | 138 | 2 | 27268481 | |
| Pubmed | Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism. | 1.56e-05 | 2 | 138 | 2 | 25994086 | |
| Pubmed | Adiposity QTL Adip20 decomposes into at least four loci when dissected using congenic strains. | 1.56e-05 | 2 | 138 | 2 | 29194435 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 11120754 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23297065 | ||
| Pubmed | The human genes for desmogleins (DSG1 and DSG3) are located in a small region on chromosome 18q12. | 1.56e-05 | 2 | 138 | 2 | 8034325 | |
| Pubmed | The anchoring protein SAP97 retains Kv1.5 channels in the plasma membrane of cardiac myocytes. | 1.56e-05 | 2 | 138 | 2 | 18245566 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 35711465 | ||
| Pubmed | The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1. | 1.56e-05 | 2 | 138 | 2 | 35039052 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34216174 | ||
| Pubmed | Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling. | 1.56e-05 | 2 | 138 | 2 | 37108197 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9405290 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PRPF31 RBL2 DDR2 CHD4 LCK YWHAG YWHAH NOMO1 CSNK1A1L CSNK1A1 SIK2 RBM8A LYN RIOK2 | 1.68e-05 | 910 | 138 | 14 | 36736316 |
| Pubmed | SP100 SMARCA5 SMCHD1 ECD DPPA2 ABCC5 CHD4 TEX14 RAD54L2 SMC2 YWHAG YWHAH PTK7 SF3B1 SMARCA1 DLG1 DLG2 UGGT2 | 1.71e-05 | 1442 | 138 | 18 | 35575683 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 2.22e-05 | 477 | 138 | 10 | 31300519 | |
| Pubmed | SMARCA5 TMA16 RARS1 CHD4 SPECC1L ACTR3B YWHAG YWHAH NMD3 CSNK1A1L SF3B1 NOM1 CLNS1A SMARCA1 RBM8A RIOK2 PLOD2 | 2.32e-05 | 1335 | 138 | 17 | 29229926 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.34e-05 | 212 | 138 | 7 | 33853758 | |
| Pubmed | 2.60e-05 | 43 | 138 | 4 | 26030138 | ||
| Pubmed | 2.60e-05 | 87 | 138 | 5 | 17979178 | ||
| Pubmed | 2.69e-05 | 15 | 138 | 3 | 10790433 | ||
| Pubmed | 2.81e-05 | 300 | 138 | 8 | 28561026 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PRPF31 SMARCA5 TMA16 SMCHD1 SMC6 CHD4 XRCC1 C5orf24 BRD4 SUV39H1 SMARCA1 | 3.31e-05 | 608 | 138 | 11 | 36089195 |
| Pubmed | 3.41e-05 | 225 | 138 | 7 | 31478661 | ||
| Pubmed | RARS1 SMCHD1 SMC2 YWHAG NOMO1 FOXRED2 SF3B1 P3H1 CLNS1A UGGT2 PLOD2 | 3.56e-05 | 613 | 138 | 11 | 22268729 | |
| Pubmed | PRPF31 MYCBP2 ZDBF2 XRCC1 RSRC2 NBAS POLR3B BBS7 SMG9 DLG1 UGGT2 NUB1 | 3.81e-05 | 733 | 138 | 12 | 34672954 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 PRPF31 DPYSL3 MYCBP2 LCK RAB11FIP1 YWHAG YWHAH TIAM1 CSNK1A1 BRD4 SIK2 NUB1 | 4.12e-05 | 861 | 138 | 13 | 36931259 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 4.13e-05 | 411 | 138 | 9 | 35182466 | |
| Pubmed | 4.26e-05 | 233 | 138 | 7 | 37704626 | ||
| Pubmed | 4.43e-05 | 320 | 138 | 8 | 28685749 | ||
| Pubmed | Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. | 4.68e-05 | 3 | 138 | 2 | 21152247 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 17611984 | ||
| Pubmed | Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. | 4.68e-05 | 3 | 138 | 2 | 24616378 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 12787134 | ||
| Pubmed | A specific N-terminal residue in Kv1.5 is required for upregulation of the channel by SAP97. | 4.68e-05 | 3 | 138 | 2 | 16466689 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 10327049 | ||
| Pubmed | Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. | 4.68e-05 | 3 | 138 | 2 | 25242043 | |
| Pubmed | Phosphorylation-dependent binding of 14-3-3 proteins controls TRESK regulation. | 4.68e-05 | 3 | 138 | 2 | 18397886 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 28655862 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 10748115 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 9677374 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 7738346 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21738833 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 11359880 | ||
| Pubmed | CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation. | 4.68e-05 | 3 | 138 | 2 | 28878021 | |
| Pubmed | Type I Interferons Control Proliferation and Function of the Intestinal Epithelium. | 4.68e-05 | 3 | 138 | 2 | 26811327 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18086677 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 19805514 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 12531897 | ||
| Pubmed | The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. | 4.68e-05 | 3 | 138 | 2 | 23728299 | |
| Pubmed | FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. | 4.68e-05 | 3 | 138 | 2 | 17245429 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 8143788 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 15277200 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 7636265 | ||
| Pubmed | Expression of desmogleins 1-3 and their clinical impacts on human lung cancer. | 4.68e-05 | 3 | 138 | 2 | 25468811 | |
| Pubmed | 4.77e-05 | 18 | 138 | 3 | 24025402 | ||
| Interaction | FAM83G interactions | 7.91e-07 | 26 | 137 | 5 | int:FAM83G | |
| Interaction | NCKIPSD interactions | 4.44e-06 | 137 | 137 | 8 | int:NCKIPSD | |
| Interaction | NELFE interactions | 9.73e-06 | 201 | 137 | 9 | int:NELFE | |
| Interaction | CCDC8 interactions | SMARCA5 EPPK1 RARS1 DSG1 MYCBP2 SMCHD1 CHD4 SPECC1L LCK SMC2 YWHAG YWHAH SF3B1 BBS7 LYN LARGE1 | 1.01e-05 | 656 | 137 | 16 | int:CCDC8 |
| Interaction | CSNK1A1 interactions | MYCBP2 ZDBF2 YWHAG YWHAH TIPARP CSNK1A1L SF3B1 TIAM1 CSNK1A1 BRD4 SIK2 NIN | 1.17e-05 | 381 | 137 | 12 | int:CSNK1A1 |
| Interaction | TRIM33 interactions | SP100 LHX4 RARS1 RBL2 SMC2 ZBTB1 TIPARP SOX7 PTPN11 SF3B1 RSPH1 BRD4 NIN | 1.34e-05 | 453 | 137 | 13 | int:TRIM33 |
| Interaction | CIC interactions | PRPF31 SMARCA5 EPPK1 LHX4 SMCHD1 ZDBF2 CHD4 RAD54L2 YWHAG YWHAH TIPARP SF3B1 C5orf24 INTS13 NOM1 CLNS1A | 1.39e-05 | 673 | 137 | 16 | int:CIC |
| Interaction | KRT18 interactions | EPPK1 SMCHD1 ECD CASP8 CHD4 YWHAG YWHAH PTPN11 FOXRED2 BBS7 BRD4 NIN | 2.98e-05 | 419 | 137 | 12 | int:KRT18 |
| Interaction | DSP interactions | RARS1 DSG1 CHD4 TEX14 LCK CALML5 ZBTB1 YWHAG YWHAH BRD4 RLIM LYN | 3.27e-05 | 423 | 137 | 12 | int:DSP |
| Interaction | AR interactions | SMARCA5 EPPK1 MYCBP2 SMCHD1 GBE1 CASP8 CHD4 LCK RAD54L2 RAB11FIP1 ZBTB1 TIPARP PTPN11 SF3B1 CSNK1A1 INTS13 BRD4 SHE LYN | 4.26e-05 | 992 | 137 | 19 | int:AR |
| Interaction | NCAM2 interactions | 4.88e-05 | 30 | 137 | 4 | int:NCAM2 | |
| Interaction | ARAP2 interactions | 4.88e-05 | 30 | 137 | 4 | int:ARAP2 | |
| Interaction | ALS2 interactions | 5.58e-05 | 31 | 137 | 4 | int:ALS2 | |
| Interaction | SNRPD3 interactions | PRPF31 CASP8 CHD4 IFIT1 ZBTB1 TIPARP SF3B1 GEMIN8 BRD4 CLNS1A RBM8A | 5.88e-05 | 380 | 137 | 11 | int:SNRPD3 |
| Interaction | EPB41 interactions | 6.09e-05 | 145 | 137 | 7 | int:EPB41 | |
| Interaction | MAP4K4 interactions | 6.14e-05 | 254 | 137 | 9 | int:MAP4K4 | |
| Interaction | SART1 interactions | 6.34e-05 | 317 | 137 | 10 | int:SART1 | |
| Interaction | FMN2 interactions | 7.46e-05 | 64 | 137 | 5 | int:FMN2 | |
| Interaction | TET2 interactions | 7.54e-05 | 150 | 137 | 7 | int:TET2 | |
| Interaction | DENND2C interactions | 8.36e-05 | 13 | 137 | 3 | int:DENND2C | |
| Interaction | TANC1 interactions | 8.64e-05 | 106 | 137 | 6 | int:TANC1 | |
| Interaction | TXNIP interactions | 1.03e-04 | 212 | 137 | 8 | int:TXNIP | |
| Interaction | CDC14A interactions | 1.12e-04 | 111 | 137 | 6 | int:CDC14A | |
| Interaction | FAM171A2 interactions | 1.17e-04 | 112 | 137 | 6 | int:FAM171A2 | |
| Interaction | GATA4 interactions | SP100 SMARCA5 TMA16 CHD4 XRCC1 SMC2 YWHAG SF3B1 INTS13 BRD4 SMARCA1 | 1.18e-04 | 411 | 137 | 11 | int:GATA4 |
| Interaction | DPYSL5 interactions | 1.23e-04 | 71 | 137 | 5 | int:DPYSL5 | |
| Interaction | NHSL3 interactions | 1.23e-04 | 113 | 137 | 6 | int:NHSL3 | |
| Interaction | TRIR interactions | 1.49e-04 | 74 | 137 | 5 | int:TRIR | |
| Interaction | FOXK2 interactions | 1.55e-04 | 225 | 137 | 8 | int:FOXK2 | |
| Interaction | COBLL1 interactions | 1.69e-04 | 76 | 137 | 5 | int:COBLL1 | |
| Interaction | KLHDC2 interactions | 1.69e-04 | 76 | 137 | 5 | int:KLHDC2 | |
| Interaction | SIPA1 interactions | 1.70e-04 | 41 | 137 | 4 | int:SIPA1 | |
| Interaction | SRC interactions | SMARCA5 RASGRF1 DDR2 CASP8 CHD4 LCK YWHAG YWHAH PTPN11 CSF1R KCNA5 TIAM1 SMARCA1 LYN | 1.76e-04 | 664 | 137 | 14 | int:SRC |
| Interaction | RPL27 interactions | RARS1 CHD4 ZBTB1 YWHAH TIPARP BMP4 SF3B1 CSNK1A1 BRD4 RLIM RBM8A | 1.79e-04 | 431 | 137 | 11 | int:RPL27 |
| Interaction | G3BP1 interactions | DPYSL3 SMARCA5 TMA16 EPPK1 RARS1 MYCBP2 CHD4 SPECC1L LCK CALML5 YWHAH TIPARP BRD4 CLNS1A SMARCA1 RIOK2 | 1.79e-04 | 835 | 137 | 16 | int:G3BP1 |
| Interaction | KIF1B interactions | 1.83e-04 | 173 | 137 | 7 | int:KIF1B | |
| Interaction | DZIP1 interactions | 1.87e-04 | 42 | 137 | 4 | int:DZIP1 | |
| Interaction | ARHGEF28 interactions | 1.87e-04 | 42 | 137 | 4 | int:ARHGEF28 | |
| Interaction | MFAP1 interactions | 1.91e-04 | 295 | 137 | 9 | int:MFAP1 | |
| Interaction | PSD3 interactions | 1.91e-04 | 78 | 137 | 5 | int:PSD3 | |
| Interaction | IQGAP1 interactions | DSG1 MYCBP2 CHD4 SPECC1L RAD54L2 SMC2 YWHAG YWHAH TIPARP BRD4 SIK2 LYN NIN | 2.00e-04 | 591 | 137 | 13 | int:IQGAP1 |
| Interaction | GAB1 interactions | 2.19e-04 | 178 | 137 | 7 | int:GAB1 | |
| Interaction | ZNF622 interactions | 2.33e-04 | 127 | 137 | 6 | int:ZNF622 | |
| Interaction | KHDRBS1 interactions | 2.39e-04 | 373 | 137 | 10 | int:KHDRBS1 | |
| Interaction | CARMIL1 interactions | 2.42e-04 | 82 | 137 | 5 | int:CARMIL1 | |
| Interaction | FAM83D interactions | 2.42e-04 | 82 | 137 | 5 | int:FAM83D | |
| Interaction | DLG4 interactions | DOCK4 GRIK5 TENM2 YWHAG NOMO1 KCNA5 TIAM1 PRICKLE2 DLG1 DLG2 LYN | 2.54e-04 | 449 | 137 | 11 | int:DLG4 |
| Interaction | GAB2 interactions | 2.64e-04 | 130 | 137 | 6 | int:GAB2 | |
| Interaction | FAM163A interactions | 2.75e-04 | 19 | 137 | 3 | int:FAM163A | |
| Interaction | ERH interactions | 2.76e-04 | 245 | 137 | 8 | int:ERH | |
| Interaction | TOP1 interactions | PRPF31 SP100 SMARCA5 RBL2 CHD4 XRCC1 TIPARP BMP4 SF3B1 TIAM1 BRD4 SMARCA1 RBM6 RBM8A | 2.84e-04 | 696 | 137 | 14 | int:TOP1 |
| Interaction | CASKIN2 interactions | 2.91e-04 | 47 | 137 | 4 | int:CASKIN2 | |
| Interaction | MACROH2A1 interactions | SP100 SMARCA5 DDR2 CHD4 SOX7 BRD4 SUV39H1 RLIM SMARCA1 LYN RIOK2 | 3.01e-04 | 458 | 137 | 11 | int:MACROH2A1 |
| Interaction | KRT78 interactions | 3.19e-04 | 87 | 137 | 5 | int:KRT78 | |
| Interaction | CORO1B interactions | 3.46e-04 | 192 | 137 | 7 | int:CORO1B | |
| Interaction | PPP1R9B interactions | DPYSL3 ABAT RASGRF1 MYCBP2 RBL2 YWHAG YWHAH CSNK1A1L TIAM1 RLIM DLG1 DLG2 TNR | 3.49e-04 | 626 | 137 | 13 | int:PPP1R9B |
| Interaction | EHBP1 interactions | 3.51e-04 | 137 | 137 | 6 | int:EHBP1 | |
| Interaction | CIAPIN1 interactions | 3.54e-04 | 89 | 137 | 5 | int:CIAPIN1 | |
| Interaction | MINK1 interactions | 3.57e-04 | 193 | 137 | 7 | int:MINK1 | |
| Interaction | TBC1D22B interactions | 3.57e-04 | 193 | 137 | 7 | int:TBC1D22B | |
| Interaction | TSR1 interactions | 3.63e-04 | 322 | 137 | 9 | int:TSR1 | |
| Interaction | PPP1R12A interactions | 3.63e-04 | 322 | 137 | 9 | int:PPP1R12A | |
| Interaction | NFATC3 interactions | 3.69e-04 | 50 | 137 | 4 | int:NFATC3 | |
| Interaction | RASSF8 interactions | 3.93e-04 | 91 | 137 | 5 | int:RASSF8 | |
| Interaction | FAM83B interactions | 3.94e-04 | 140 | 137 | 6 | int:FAM83B | |
| Interaction | ABCC5 interactions | 3.99e-04 | 51 | 137 | 4 | int:ABCC5 | |
| Interaction | FAM83H interactions | 4.09e-04 | 141 | 137 | 6 | int:FAM83H | |
| Interaction | CALR3 interactions | 4.25e-04 | 142 | 137 | 6 | int:CALR3 | |
| Interaction | PRP4K interactions | 4.25e-04 | 329 | 137 | 9 | int:PRP4K | |
| Interaction | KIF26B interactions | 4.30e-04 | 52 | 137 | 4 | int:KIF26B | |
| Interaction | PPP1R3D interactions | 4.31e-04 | 22 | 137 | 3 | int:PPP1R3D | |
| Interaction | TRPS1 interactions | 4.41e-04 | 143 | 137 | 6 | int:TRPS1 | |
| Interaction | MYO1E interactions | 4.70e-04 | 202 | 137 | 7 | int:MYO1E | |
| Interaction | AHNAK2 interactions | 4.75e-04 | 145 | 137 | 6 | int:AHNAK2 | |
| Interaction | IRS1 interactions | 4.75e-04 | 145 | 137 | 6 | int:IRS1 | |
| Interaction | JUP interactions | 4.87e-04 | 485 | 137 | 11 | int:JUP | |
| Interaction | CPSF3 interactions | 4.92e-04 | 146 | 137 | 6 | int:CPSF3 | |
| Interaction | CDC42BPA interactions | 4.92e-04 | 146 | 137 | 6 | int:CDC42BPA | |
| Interaction | BAZ1B interactions | 4.98e-04 | 204 | 137 | 7 | int:BAZ1B | |
| Interaction | CCAR2 interactions | 5.05e-04 | 337 | 137 | 9 | int:CCAR2 | |
| Interaction | CLASP2 interactions | 5.10e-04 | 147 | 137 | 6 | int:CLASP2 | |
| Interaction | TIAM1 interactions | 5.13e-04 | 205 | 137 | 7 | int:TIAM1 | |
| Interaction | DDX39B interactions | PRPF31 DSG1 CHD4 SPECC1L CALML5 LCT YWHAG TIPARP SF3B1 BRD4 RBM8A LYN | 5.25e-04 | 570 | 137 | 12 | int:DDX39B |
| Interaction | KIF21B interactions | 5.33e-04 | 55 | 137 | 4 | int:KIF21B | |
| Interaction | PRPF4 interactions | 5.41e-04 | 271 | 137 | 8 | int:PRPF4 | |
| Interaction | SNRPD2 interactions | PRPF31 ECD CHD4 IFIT1 YWHAH TIPARP SF3B1 GEMIN8 CLNS1A RBM8A | 5.43e-04 | 414 | 137 | 10 | int:SNRPD2 |
| Interaction | SMARCA5 interactions | SMARCA5 SMC6 CHD4 SMC2 TIPARP POLR3B SF3B1 BRD4 RLIM SMARCA1 | 5.53e-04 | 415 | 137 | 10 | int:SMARCA5 |
| Interaction | EPB41L3 interactions | 5.54e-04 | 272 | 137 | 8 | int:EPB41L3 | |
| Interaction | DDX42 interactions | 5.59e-04 | 208 | 137 | 7 | int:DDX42 | |
| Interaction | STAT1 interactions | 5.62e-04 | 342 | 137 | 9 | int:STAT1 | |
| Interaction | H3C3 interactions | PRPF31 SMARCA5 TMA16 SMCHD1 SMC6 CHD4 C5orf24 BRD4 SUV39H1 RLIM SMARCA1 | 5.77e-04 | 495 | 137 | 11 | int:H3C3 |
| Interaction | TFCP2L1 interactions | 5.78e-04 | 99 | 137 | 5 | int:TFCP2L1 | |
| Interaction | HNRNPCL2 interactions | 5.81e-04 | 274 | 137 | 8 | int:HNRNPCL2 | |
| Cytoband | 22q12.3 | 1.36e-04 | 33 | 138 | 3 | 22q12.3 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 4.41e-04 | 7 | 84 | 2 | 1053 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 4.41e-04 | 7 | 84 | 2 | 761 | |
| GeneFamily | Desmosomal cadherins | 4.41e-04 | 7 | 84 | 2 | 1188 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 8.44e-04 | 40 | 84 | 3 | 321 | |
| GeneFamily | SH2 domain containing | 1.26e-03 | 101 | 84 | 4 | 741 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 SP100 SMARCA5 MYCBP2 SMCHD1 DDR2 GBE1 CASP8 SPECC1L TIPARP NBAS TIAM1 CSNK1A1 SMARCA1 RBM6 DLG1 N4BP2L2 LYN PLOD2 | 1.26e-07 | 856 | 138 | 19 | M4500 |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN | 1.10e-05 | 199 | 138 | 8 | M7985 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SP100 SMARCA5 MYCBP2 SMCHD1 CASP8 RSRC2 IFIT1 SF3B1 N4BP2L2 NUB1 | 7.25e-10 | 200 | 138 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-07 | 188 | 138 | 8 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-06 | 185 | 138 | 7 | ef996f4cdbc3971c6c0460d13df64b075ab22154 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-06 | 185 | 138 | 7 | d51342a3979bd728a80e04126059a3fd8a0dbe3b | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 187 | 138 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.86e-06 | 198 | 138 | 7 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.06e-06 | 200 | 138 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.21e-06 | 141 | 138 | 6 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 182 | 138 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-3|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.28e-05 | 109 | 138 | 5 | 5d194bf95eb777fb4d01bbe5b1639f17ea1bc11a | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.30e-05 | 183 | 138 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.30e-05 | 183 | 138 | 6 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 183 | 138 | 6 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.44e-05 | 185 | 138 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 186 | 138 | 6 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 188 | 138 | 6 | 20072a2a3f9ecbe727c850629f19420cf60e4bc5 | |
| ToppCell | facs-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 188 | 138 | 6 | dd817059e1b4225e84733559f7839cc973b7dfd6 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 188 | 138 | 6 | 6ab5ce8569f896a0fe7a76b8b4a83661e5499b8c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-05 | 190 | 138 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 193 | 138 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 193 | 138 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 193 | 138 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.19e-05 | 194 | 138 | 6 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.47e-05 | 197 | 138 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.47e-05 | 197 | 138 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.57e-05 | 198 | 138 | 6 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-05 | 199 | 138 | 6 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.67e-05 | 199 | 138 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.67e-05 | 199 | 138 | 6 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.67e-05 | 199 | 138 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 3.67e-05 | 199 | 138 | 6 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.78e-05 | 200 | 138 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-05 | 200 | 138 | 6 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.78e-05 | 200 | 138 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-05 | 200 | 138 | 6 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 200 | 138 | 6 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.78e-05 | 200 | 138 | 6 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 200 | 138 | 6 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.31e-05 | 130 | 138 | 5 | 6c6a8b77af08b30b424d4f5def37315d3c6e28b2 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast-mesenchymal_B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.31e-05 | 130 | 138 | 5 | 0706092f6b466585b3b4808b3b982a122d66cfcf | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.21e-05 | 146 | 138 | 5 | 26493014daa432db721613ef480d133f3da9eb58 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.15e-04 | 153 | 138 | 5 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 158 | 138 | 5 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-04 | 159 | 138 | 5 | 1dde4d19cc0fde7ebbccb4c31bb845a92206021b | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.68e-04 | 166 | 138 | 5 | f8f8423423d72f0ea0266b59126abb27beb23094 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.73e-04 | 167 | 138 | 5 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.78e-04 | 168 | 138 | 5 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.78e-04 | 168 | 138 | 5 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 169 | 138 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 1.98e-04 | 172 | 138 | 5 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-04 | 174 | 138 | 5 | b1bcd5f4505d2ccef4183fcfbf1de81964b3f9e0 | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.15e-04 | 175 | 138 | 5 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.15e-04 | 175 | 138 | 5 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-04 | 176 | 138 | 5 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-04 | 176 | 138 | 5 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 178 | 138 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Children_(3_yrs)|World / Lineage, Cell type, age group and donor | 2.32e-04 | 178 | 138 | 5 | df2ecd3214590b914f2762db57efe780ba038db3 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-04 | 178 | 138 | 5 | a3f95f0002f408b5b6c57e28b297b5b2737e919c | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 179 | 138 | 5 | 6f51a4580c06fc55cc764052c9b26f7c55660282 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 179 | 138 | 5 | f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 179 | 138 | 5 | a6ce1fa338d4905bd6afef00763ac83e916a0b37 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-04 | 180 | 138 | 5 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.45e-04 | 180 | 138 | 5 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.51e-04 | 181 | 138 | 5 | c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 181 | 138 | 5 | 2e15c46e8260bb04d8264478c19a707221996026 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-04 | 181 | 138 | 5 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.57e-04 | 182 | 138 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.57e-04 | 182 | 138 | 5 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-04 | 182 | 138 | 5 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.57e-04 | 182 | 138 | 5 | 4cd5eb13f78f4f377932c50ac2acb4ac0cd14c12 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.64e-04 | 183 | 138 | 5 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 183 | 138 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 2.64e-04 | 183 | 138 | 5 | 6c55fd737ed31f5b1aa41dc4dba7240521c19022 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 183 | 138 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.77e-04 | 185 | 138 | 5 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.84e-04 | 186 | 138 | 5 | 0cc7504297fd0c97ea50e4b3ff58fcedc4c1cfaa | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.84e-04 | 186 | 138 | 5 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.84e-04 | 186 | 138 | 5 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.84e-04 | 186 | 138 | 5 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.84e-04 | 186 | 138 | 5 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.84e-04 | 186 | 138 | 5 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.84e-04 | 186 | 138 | 5 | b70cd94c651b56dcf2e55554533a5f1130845390 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.91e-04 | 187 | 138 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-04 | 187 | 138 | 5 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 187 | 138 | 5 | 7abc174a06bf07b5f6efe0a370fbb1c23e0079b3 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 187 | 138 | 5 | f9863428943b695f26bd680e6fc5aeb38ec3422f | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 187 | 138 | 5 | b0a2e417b4eb9a185033e89c5df3431c11488688 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.91e-04 | 187 | 138 | 5 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 2.91e-04 | 187 | 138 | 5 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 188 | 138 | 5 | 5df5a0890e17d19f55770525345a656253696887 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.99e-04 | 188 | 138 | 5 | 3e94d105ca96ceb5fdcca39a8050217913bc02da | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.99e-04 | 188 | 138 | 5 | 89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-04 | 188 | 138 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-04 | 188 | 138 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.99e-04 | 188 | 138 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-04 | 188 | 138 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 188 | 138 | 5 | 9e923b0d79495ee1a3a097741a877f25d439eda3 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.99e-04 | 188 | 138 | 5 | de6a270b6e4fe09c39a52c296632d86ada98465b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 188 | 138 | 5 | 14dbc985abc2012c9f53deb243d465e4175f419f | |
| ToppCell | COVID-19_Mild-pDC|COVID-19_Mild / Disease condition and Cell class | 2.99e-04 | 188 | 138 | 5 | 62d33d2990d4a2d32bd0863147e47f656df1966e | |
| Disease | Intellectual Disability | RARS1 APC2 PEX6 SPECC1L PCDH12 YWHAG POLR3B BBS7 BRD4 RLIM TET3 MAB21L1 LARGE1 | 1.66e-07 | 447 | 136 | 13 | C3714756 |
| Disease | Global developmental delay | 2.90e-06 | 133 | 136 | 7 | C0557874 | |
| Disease | carcinoma (implicated_via_orthology) | 1.18e-05 | 64 | 136 | 5 | DOID:305 (implicated_via_orthology) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 2.30e-04 | 26 | 136 | 3 | DOID:234 (is_implicated_in) | |
| Disease | brain disease (implicated_via_orthology) | 3.13e-04 | 6 | 136 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 3.55e-04 | 30 | 136 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 4.31e-04 | 32 | 136 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Abnormality of the eye | 4.36e-04 | 7 | 136 | 2 | C4316870 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 4.36e-04 | 7 | 136 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | fat body mass | 5.24e-04 | 217 | 136 | 6 | EFO_0005409 | |
| Disease | benign neoplasm (implicated_via_orthology) | 5.80e-04 | 8 | 136 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | Abnormality of the face | 7.43e-04 | 9 | 136 | 2 | C4025871 | |
| Disease | Cleft palate with cleft lip | 7.43e-04 | 9 | 136 | 2 | C0158646 | |
| Disease | kidney disease (implicated_via_orthology) | 8.98e-04 | 41 | 136 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | Nephroblastoma | 9.26e-04 | 10 | 136 | 2 | Orphanet_654 | |
| Disease | forced expiratory volume, response to bronchodilator | 1.10e-03 | 445 | 136 | 8 | EFO_0004314, GO_0097366 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 1.13e-03 | 11 | 136 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | heat shock protein beta-1 measurement | 1.35e-03 | 12 | 136 | 2 | EFO_0010595 | |
| Disease | cancer (implicated_via_orthology) | 1.56e-03 | 268 | 136 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Osteogenesis Imperfecta | 1.59e-03 | 13 | 136 | 2 | C0029434 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 2.13e-03 | 15 | 136 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | taste liking measurement | 2.20e-03 | 388 | 136 | 7 | EFO_0010155 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 2.43e-03 | 16 | 136 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | central nervous system disease (implicated_via_orthology) | 2.43e-03 | 16 | 136 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | household income | 2.92e-03 | 304 | 136 | 6 | EFO_0009695 | |
| Disease | response to bronchodilator, FEV/FEC ratio | SP100 SUPT3H GRIK5 TMEM132B TENM2 NMD3 CLNS1A PPM1L DLG2 LARGE1 | 2.97e-03 | 766 | 136 | 10 | EFO_0004713, GO_0097366 |
| Disease | Astigmatism | 3.05e-03 | 129 | 136 | 4 | HP_0000483 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.70e-03 | 67 | 136 | 3 | C3463824 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 3.79e-03 | 20 | 136 | 2 | DOID:3328 (is_marker_for) | |
| Disease | Headache, HbA1c measurement | 4.18e-03 | 21 | 136 | 2 | EFO_0004541, HP_0002315 | |
| Disease | Anophthalmia-microphthalmia syndrome | 4.18e-03 | 21 | 136 | 2 | cv:C5680330 | |
| Disease | stomach cancer (is_implicated_in) | 4.53e-03 | 72 | 136 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | CCL24 measurement | 4.59e-03 | 22 | 136 | 2 | EFO_0009418 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ARLAEQAERYDDMAA | 11 | P61981 | |
| RDDGMVEVYSFDNAN | 261 | Q8IWZ6 | |
| FDYEVRRTFNNDMLL | 451 | Q9P2K9 | |
| LFRMDEEQQIYTEQG | 61 | Q9BXI3 | |
| ARLAEQAERYDDMAS | 11 | Q04917 | |
| EYRDAQEFGADVRLM | 411 | O60885 | |
| ENREYLAEIMFESFN | 121 | Q9P1U1 | |
| DVFRYRQRNSSMDEE | 176 | Q155Q3 | |
| DGRDYHFVTSREQME | 756 | Q12959 | |
| QSAAEYNIFEGMELR | 426 | Q14195 | |
| EAYGDEVMSRARVFD | 31 | Q3ZCU0 | |
| RDEVQAMIYDDGASR | 251 | Q9BXJ3 | |
| LEQRYMDLAENARFE | 491 | Q69YQ0 | |
| EQGDFYITGDRARMD | 446 | Q6NUN0 | |
| VNDLEREGQYMFTDN | 211 | Q9Y6Z7 | |
| IQRDLYTQFMDRFRD | 586 | Q9Y4B4 | |
| DYMRDLYRLQSGEEE | 81 | P12644 | |
| DGRVNYEEFARMLAQ | 131 | Q9NZT1 | |
| EGSAQYRERLEMAEN | 351 | O95905 | |
| EYRDEDGRETLQTMG | 796 | O95450 | |
| NIEDIYRFQMGFVRD | 151 | O43307 | |
| SRARMREDYDSVEQD | 46 | Q9Y5S9 | |
| MQEFRLGVRLYSEEQ | 206 | Q32P28 | |
| AMNVYETTEFDQLRR | 316 | Q7Z3E1 | |
| TDYRITDFGEFMREN | 411 | Q9NVM9 | |
| LEMDQAEEAQYGRFL | 656 | Q96PH1 | |
| ALRTMDYEAIQDFQF | 516 | Q9Y5F3 | |
| RSLNYEEMAGFEFQV | 521 | Q9NPG4 | |
| SQENIDRLVYMGFDA | 491 | Q9Y5A7 | |
| DMEEEERGDLIQFYN | 996 | Q08999 | |
| MFRDSQYSARIEENI | 266 | P32926 | |
| KEEFQQDMSRRYGFA | 731 | O95461 | |
| QQYREAMEDEANRAD | 931 | Q9HCI5 | |
| EMGLLRREADFYQVQ | 76 | Q4G0X4 | |
| DARNMARDVQNTFYD | 631 | P16435 | |
| NMEITEELRQYFAET | 136 | Q9NWZ8 | |
| EFRRMFSQYAEELTD | 31 | Q9NVR5 | |
| NGYIEIMFEFDRIRN | 266 | Q16832 | |
| EYGTLDNMREVVERN | 386 | O43451 | |
| RGNYLVDVDGNRMLD | 81 | P80404 | |
| RDLAMFNINIDDDYV | 1571 | A6NKB5 | |
| MYVGQSEENVREVFA | 776 | Q13608 | |
| LEDDMSAVEFRQTGY | 576 | Q15155 | |
| QFRADRAAEQVMEYQ | 156 | Q9NX36 | |
| DMRAQYEELAEQNRR | 316 | Q2M2I5 | |
| QEDVEAARRYVQFMG | 1611 | P09848 | |
| AQIAEGMAFIEERNY | 346 | P06239 | |
| NRQLATGDEFYLMED | 121 | Q969G2 | |
| RIRQGEEQRFTCYME | 271 | Q29980 | |
| IEQSRRDDMESLGYV | 196 | Q8N752 | |
| EMREDSARVYENVGL | 571 | Q06124 | |
| DDNDNFAMRVPYDRV | 321 | Q8IWF2 | |
| EEMNRRLDEEYSNLN | 516 | Q495T6 | |
| EGYQDLATRQELMAF | 1326 | A2RRP1 | |
| GEIRTMNNFLDREQY | 216 | Q02413 | |
| TLRSEMNERNYFVRD | 471 | O00469 | |
| YDEQFQGMSLLVRSD | 31 | Q6ZMV5 | |
| EDYDQFMRQRSFQES | 721 | Q7Z3G6 | |
| GEVTFENAEMRYREN | 1191 | O15440 | |
| LSFDEEYRRAMNELG | 421 | O95996 | |
| DFGLARDIMNDSNYI | 796 | P07333 | |
| NNFDRDMNRLEERYG | 581 | Q04446 | |
| NMAGVRTEDSIRDYE | 201 | P54105 | |
| RFYQLGDEAMERFRE | 201 | P22460 | |
| DYERLEAFQQRMLNE | 1341 | Q8N1I0 | |
| LNEDAMRAADQFDIY | 21 | Q7Z6I8 | |
| GAMFQDQLVDYRVEF | 2361 | Q9UFH2 | |
| YNTRISFENREEDMI | 481 | Q5T5S1 | |
| EEQMEEYRGRTTFVS | 86 | Q7KYR7 | |
| MDFSRNLYDIGEQLD | 1 | Q14790 | |
| DFSAQIAEGMAYIER | 346 | P07948 | |
| GNMNEALEYYERALR | 451 | P09914 | |
| VDGRDYHFVISREQM | 721 | Q15700 | |
| RMVEYDGLTGRVEFN | 351 | Q16478 | |
| EEQLRRAAYLNMSED | 1796 | Q14839 | |
| RSYEMNERAEETNTV | 161 | Q7Z7J5 | |
| AFAMEQREEERYGAE | 346 | Q9NUT2 | |
| IERGESFYQDRMNDI | 331 | P54136 | |
| LDFLGRQDTDYRSME | 391 | P78332 | |
| FRMEGEDALVTQYQS | 911 | Q6WKZ4 | |
| QEEVFRNLDAQYEMA | 396 | Q7L4I2 | |
| VELLGDMDRNEFDQY | 321 | Q9BT81 | |
| RERYRDNDSDLALGM | 191 | Q96CS7 | |
| FQMYDEGEREINITS | 1071 | A6NHR9 | |
| EYMLESEDRGVQRDL | 396 | Q8IWB6 | |
| EMYNEARRQLRDESQ | 296 | Q8WXA3 | |
| KMGFDRENVYEELRQ | 976 | P28370 | |
| LGDSQDFRDYMESLQ | 1061 | Q14DG7 | |
| RFISSLNEMDNRYEG | 51 | Q13394 | |
| FFLQEERLTQMRNEY | 526 | Q8N4C6 | |
| NIREMYNDAERFSDF | 476 | Q6UWF7 | |
| IEQSRRDDMESLGYV | 196 | P48729 | |
| RRGYFDEEMNRVLAD | 3431 | P58107 | |
| YSIQGRRDHMEDRFE | 96 | Q5SGD2 | |
| EAYREIIRDNNMDFT | 956 | O43147 | |
| AERRDAMYQEELGGQ | 471 | Q6ZNE9 | |
| EDQRTYVFRAQSAEM | 231 | Q9H0W8 | |
| EYDMGSVQRDLNFLE | 516 | Q9H0K1 | |
| IYRFSEEGMVNARFD | 2076 | Q9NT68 | |
| DDNLFQDEMRYLRST | 3411 | O75592 | |
| GSEFQDQTRIRFMLE | 536 | Q5C9Z4 | |
| EQHGEYRLTDMERGE | 181 | Q8WYR4 | |
| MVSSYVGENAEFERQ | 111 | P55809 | |
| RNQVVFSMLEAEAEY | 241 | Q13972 | |
| RAGEELTFDYNMQVD | 356 | O43463 | |
| FGGIYENESRNTEML | 226 | P51788 | |
| LDAAQRDLYRDVMQE | 31 | Q9C0F3 | |
| RDLYRDVMQENYGNV | 36 | Q9C0F3 | |
| ERQTRIMDSAQYAEF | 171 | O75486 | |
| QGVYENFRRELEMST | 381 | Q13009 | |
| YEGMRDCINTIRQEE | 366 | Q96AG3 | |
| DIDNMDEYVRNTTAR | 616 | O75533 | |
| SQMDRLDREEAFYQF | 21 | Q9NVW2 | |
| VNNLSEEDYRLMRDN | 36 | Q9NVW2 | |
| EEDYRLMRDNNLLGT | 41 | Q9NVW2 | |
| RMFTEDQGVDDRLLY | 36 | P23497 | |
| QGRYELRVDMRDGQE | 1221 | Q92752 | |
| NRMSFGEIEEDAYQE | 376 | Q8WWY3 | |
| TEDRRNEAKGFEIMY | 1231 | Q9HCK1 | |
| GDREEIMRQYQEARE | 886 | Q96SB8 | |
| DRQIFRFSEDGMVNA | 2001 | Q9P273 | |
| MEELAQGYRNFEDFL | 611 | Q9NW08 | |
| YETFNREMSREAGNN | 221 | O43151 | |
| RDEENVGAMNQYRTR | 466 | Q9BVS4 | |
| RAMNVLTEAEERYND | 986 | O95347 | |
| GVRMYEDTVARNGNE | 141 | Q9Y2K1 | |
| AQIGREGMDDVYRAD | 431 | Q8TCN5 | |
| VTAFNGELEDYMSDR | 566 | P18887 | |
| INGLRVDMDVYDAFS | 381 | Q9NYU1 | |
| EEKMQTDRANRFEYL | 81 | O60264 | |
| QRDAERVGENDGYME | 216 | Q5VZ18 | |
| NYRSLFMEDEEGQSE | 536 | Q2TAA8 | |
| RDAQMQDESQYFFRV | 106 | Q96LC7 | |
| YRNQMLISEDSRFEV | 446 | Q13308 | |
| AVMLENYRNLEFVDS | 51 | Q0VGE8 | |
| TMERERQQFEGYGLE | 116 | Q96EY4 | |
| EMEFQRCQYVVGRER | 116 | Q5SQQ9 | |
| SVDGEDNFRYFLAQM | 266 | Q15048 | |
| MQDRYVSNGFCEVRE | 356 | Q92802 | |
| AEQEAARRIFYDGIM | 86 | Q8N9F0 | |
| RERENMDTDDERQYQ | 426 | Q96D46 |